|
Volumn 72, Issue 7, 2011, Pages 977-978
|
Antidepressant medication treatment during pregnancy: Prevalence of use, clinical implications, and alternatives
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
FLUOXETINE;
SEROTONIN UPTAKE INHIBITOR;
ANTENATAL DEPRESSION;
ANXIETY DISORDER;
BRAZELTON NEONATAL BEHAVIORAL ASSESSMENT SCALE;
CHILD BEHAVIOR;
CLINICAL PRACTICE;
CLINICAL TRIAL (TOPIC);
DEPRESSION;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG USE;
DRUG WITHDRAWAL;
FETOPLACENTAL UNIT;
GESTATIONAL AGE;
HAMILTON SCALE;
HEALTH CARE SYSTEM;
HUMAN;
LIGHT INTENSITY;
MAJOR DEPRESSION;
MATERNAL DISEASE;
OUTCOME ASSESSMENT;
PATIENT MONITORING;
PHOTOTHERAPY;
PREGNANCY;
PREGNANCY OUTCOME;
PRENATAL DRUG EXPOSURE;
PRIORITY JOURNAL;
SAMPLE SIZE;
SHORT SURVEY;
SOCIAL STATUS;
UMBILICAL CORD BLOOD;
ANTIDEPRESSIVE AGENTS;
COMBINED MODALITY THERAPY;
DEPRESSIVE DISORDER, MAJOR;
DRUG UTILIZATION;
FEMALE;
GESTATIONAL AGE;
HALF-LIFE;
HUMANS;
INFANT, NEWBORN;
MATERNAL-FETAL EXCHANGE;
PHOTOTHERAPY;
PREGNANCY;
PREGNANCY COMPLICATIONS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
EID: 79960701786
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/JCP.11f07206 Document Type: Short Survey |
Times cited : (9)
|
References (2)
|